Announcement on presentation of KC1036 for the treatment of advanced thymic tumors in the form of a poster at the 2026 ASCO Annual Meeting

About this update from Beijing Konruns Pharmaceutical Co., Ltd. Class A

Announcement on presentation of KC1036 for the treatment of advanced thymic tumors in the form of a poster at the 2026 ASCO Annual Meeting The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Beijing Konruns Pharmaceutical Co., Ltd. Class A